Cargando…

Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis

Lignan polyphenols derived from plants are metabolized by bacteria in the gut to mammalian lignans, such as enterolactone (ENL) and enterodiol (END). Mammalian lignan intake has been reported to be associated with obesity and low blood glucose levels. However, the factors that are responsible for in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujitani, Tomoko, Harada Sassa, Mariko, Lyu, Zhaoqing, Fujii, Yukiko, Harada, Kouji H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695372/
https://www.ncbi.nlm.nih.gov/pubmed/38048315
http://dx.doi.org/10.1371/journal.pone.0295185
_version_ 1785153552092495872
author Fujitani, Tomoko
Harada Sassa, Mariko
Lyu, Zhaoqing
Fujii, Yukiko
Harada, Kouji H.
author_facet Fujitani, Tomoko
Harada Sassa, Mariko
Lyu, Zhaoqing
Fujii, Yukiko
Harada, Kouji H.
author_sort Fujitani, Tomoko
collection PubMed
description Lignan polyphenols derived from plants are metabolized by bacteria in the gut to mammalian lignans, such as enterolactone (ENL) and enterodiol (END). Mammalian lignan intake has been reported to be associated with obesity and low blood glucose levels. However, the factors that are responsible for individual differences in the metabolic capacity for ENL and END are not well understood. In the present study, the effects of enterotypes of isoflavone metabolism, equol producers (EQP) and O-desmethylangolensin producers (O-DMAP), on lignan metabolism were examined. EQP was defined by urinary daidzein (DAI) and equol concentrations as log(equol/DAI) ≥ –1.42. O-DMAP was defined by urinary DAI and O-DMA concentrations as O-DMA/DAI > 0.018. Isoflavone and lignan concentrations in urine samples from 440 Japanese women were measured by gas chromatography-mass spectrometry. Metabolic enterotypes were determined from the urinary equol and O-DMA concentrations. Urinary END and ENL concentrations were compared in four groups, combinations of EQP (+/–) and O-DMAP (+/–). The urinary lignan concentration was significantly higher in the O-DMAP/EQP group (ENL: P<0.001, END: P<0.001), and this association remained significant after adjusting for several background variables (END: β = 0.138, P = 0.00607 for EQP and β = 0.147, P = 0.00328 for O-DMAP; ENL: β = 0.312, P<0.001 for EQP and β = 0.210, P<0.001 for O-DMAP). The ENL/END ratio was also highest in the O-DMAP/EQP group, indicating that equol and O-DMA metabolizing gut bacteria may be involved in lignan metabolism. In conclusion, urinary lignan concentrations were significantly higher in groups containing either EQP or O-DMAP than in the non-EQP/non-O-DMAP group. The variables and participants in this study were limited, which the possibility of confounding by other variables cannot be ruled out. However, there are no established determinants of lignan metabolism to date. Further research is needed to determine what factors should be considered, and to examine in different settings to confirm the external validity.
format Online
Article
Text
id pubmed-10695372
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-106953722023-12-05 Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis Fujitani, Tomoko Harada Sassa, Mariko Lyu, Zhaoqing Fujii, Yukiko Harada, Kouji H. PLoS One Research Article Lignan polyphenols derived from plants are metabolized by bacteria in the gut to mammalian lignans, such as enterolactone (ENL) and enterodiol (END). Mammalian lignan intake has been reported to be associated with obesity and low blood glucose levels. However, the factors that are responsible for individual differences in the metabolic capacity for ENL and END are not well understood. In the present study, the effects of enterotypes of isoflavone metabolism, equol producers (EQP) and O-desmethylangolensin producers (O-DMAP), on lignan metabolism were examined. EQP was defined by urinary daidzein (DAI) and equol concentrations as log(equol/DAI) ≥ –1.42. O-DMAP was defined by urinary DAI and O-DMA concentrations as O-DMA/DAI > 0.018. Isoflavone and lignan concentrations in urine samples from 440 Japanese women were measured by gas chromatography-mass spectrometry. Metabolic enterotypes were determined from the urinary equol and O-DMA concentrations. Urinary END and ENL concentrations were compared in four groups, combinations of EQP (+/–) and O-DMAP (+/–). The urinary lignan concentration was significantly higher in the O-DMAP/EQP group (ENL: P<0.001, END: P<0.001), and this association remained significant after adjusting for several background variables (END: β = 0.138, P = 0.00607 for EQP and β = 0.147, P = 0.00328 for O-DMAP; ENL: β = 0.312, P<0.001 for EQP and β = 0.210, P<0.001 for O-DMAP). The ENL/END ratio was also highest in the O-DMAP/EQP group, indicating that equol and O-DMA metabolizing gut bacteria may be involved in lignan metabolism. In conclusion, urinary lignan concentrations were significantly higher in groups containing either EQP or O-DMAP than in the non-EQP/non-O-DMAP group. The variables and participants in this study were limited, which the possibility of confounding by other variables cannot be ruled out. However, there are no established determinants of lignan metabolism to date. Further research is needed to determine what factors should be considered, and to examine in different settings to confirm the external validity. Public Library of Science 2023-12-04 /pmc/articles/PMC10695372/ /pubmed/38048315 http://dx.doi.org/10.1371/journal.pone.0295185 Text en © 2023 Fujitani et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fujitani, Tomoko
Harada Sassa, Mariko
Lyu, Zhaoqing
Fujii, Yukiko
Harada, Kouji H.
Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
title Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
title_full Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
title_fullStr Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
title_full_unstemmed Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
title_short Association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: A cross-sectional analysis
title_sort association between lignan polyphenol bioavailability and enterotypes of isoflavone metabolism: a cross-sectional analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695372/
https://www.ncbi.nlm.nih.gov/pubmed/38048315
http://dx.doi.org/10.1371/journal.pone.0295185
work_keys_str_mv AT fujitanitomoko associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis
AT haradasassamariko associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis
AT lyuzhaoqing associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis
AT fujiiyukiko associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis
AT haradakoujih associationbetweenlignanpolyphenolbioavailabilityandenterotypesofisoflavonemetabolismacrosssectionalanalysis